Brincidofovir
10 mg/ml Oral suspension
Previous product name: | |
On the market: | - |
Strength numeric with unit: | |
ATC code: | J05AB17 |
Product type: | Licensläkemedel |
NPL id: | 20150922000146 |
Swedish approval number: | |
Approval number: | |
Marketing authorisation number: | |
Approval date: | |
Authorisation procedure: | Ospecificerad |
OriginID license: | |
Approval country license: |
Dose dispensing: | Nej |
Dose disp. shelf life: | |
Contains lactose: | Ospecificerad |
Contains latex: | Ospecificerad |
Controlled medicinal product: | Nej |
Biological medicinal product: | |
Antimicrobial drug: | Ja |
Narcotic class: | Ej narkotikaklassad |
Prescription drug: | Receptbelagt |
Repeat prescription: | |
Additional monitoring: | Nej |
Dispensing restriction: | |
Human use only: |
Pharmaceutical product 1:
Ingredient role | Substance | Quantity | Unit | Additional | CAS no. |
---|---|---|---|---|---|
Aktiv beståndsdel | brincidofovir | Angiven mängd är den avsedda, med normal variation | 444805-28-1 |
Company:
Innehavare av godkännande för försäljning: |
---|
MAH Saknas. Chimerix (Tillverkare), Chimerix, Inc., 2505 Meridian Parkway, Suite 340, Durham, NC 27713, USA |